化学发光免疫分析 (CLIA) 市场快照
| Study Period: | 2018 - 2026 |
| Base Year: | 2021 |
| Fastest Growing Market: | Asia Pacific |
| Largest Market: | North America |
| CAGR: | 6.6 % |
|
Need a report that reflects how COVID-19 has impacted this market and its growth?
市场概况
预计化学发光免疫分析 (CLIA) 市场在预测期内将以 6.6% 的复合年增长率增长。化学发光免疫分析 (CLIA) 市场增长的主要因素是心血管疾病、糖尿病、自身免疫性疾病、癌症等慢性病发病率的上升。
患有慢性病的人口增加正在推动市场增长。心脏病仍然是美国的主要死因。2018 年，根据 AHA 的统计数据，大约 720,000 名美国人经历了冠状动脉事件，大约 335,000 人经历了反复发作的事件。在将化学发光免疫分析 (CLIA) 市场推向新的水平方面发挥关键作用的因素很少，其中之一是与化学发光分析仪及其技术相关的持续发展，预计将进一步推动全球增长化学发光免疫分析（CLIA）市场。
报告范围
根据报告的范围，化学发光 (CL) 被描述为由于化学反应产生光而产生的电磁辐射放电。化学发光免疫测定法 (CLIA) 是一种将化学发光技术与免疫化学反应相结合的测定法。
| By Product Type | ||||
| ||||
| ||||
| Consumables |
| By Application | |
| Oncology | |
| Autoimmune Disorder | |
| Infectious Disease | |
| Cardiovascular Disease | |
| Endocrine Disorders | |
| Others |
| By End User | |
| Pharmaceutical and Biotechnology Companies | |
| Hospital and Clinical Laboratories | |
| Others |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
主要市场趋势
试剂部门预计将在化学发光免疫分析 (CLIA) 市场中占有最大的市场份额
由于与分析仪系统相比，试剂更换频率相对较高，预计试剂部分将在预测期内继续占据主导地位。
根据 GLOBOCAN 2018 的统计数据，全球有 18,078,957 人患有癌症。亚洲仍然是癌症发病率上升的主要贡献者，据报道份额为 48.4%，其次是欧洲、北美和拉丁美洲、非洲和大洋洲，分别为 23.4%、13.2%、7.8%、5.8% 和 1.4% ％ 分别。
因此，对超灵敏疾病诊断、更好的准确性和质量的需求不断增加，以及有望推动试剂市场的新测试选项的不断发展。特别是对癌症、心血管和其他慢性疾病的高内涵诊断和临床研究的需求不断增加，也正在加强试剂的市场增长。
To understand key trends, Download Sample Report
北美在市场上占主导地位，预计在预测期内也会如此
在整个预测期内，预计北美将主导整个化学发光免疫分析 (CLIA) 市场。这是由于心血管疾病和癌症等慢性病发病率上升等因素，而测试产品的革命是主要因素之一。
在北美地区，由于心血管疾病和其他慢性病患者人数不断增加等因素，美国拥有最大的市场份额。根据美国疾病控制与预防中心 (CDC) 和美国心脏协会 (AHA) 的说法，冠心病是美国死亡的主要原因，并伴有中风、高血压、冠心病、心力衰竭和其他心血管疾病。然而，该国不断增长的老年人口和与化学发光免疫分析（CLIA）相关的发展，也将有助于刺激该地区对 CLIA 的需求。
To understand geography trends, Download Sample Report
竞争格局
化学发光免疫分析 (CLIA) 市场竞争适度，由主要参与者组成。就市场份额而言，目前很少有主要参与者占据市场主导地位。一些知名企业正积极与其他公司进行收购和新产品发布，以巩固其在全球的市场地位。目前主导市场的一些公司包括 F. Hoffmann-La Roche AG、Mindray Medical International Limited、Siemens Healthcare GmbH、Beckman Coulter Inc.（Danaher Corporation）和 DiaSorin SpA
Table of Contents
-
1. INTRODUCTION
-
1.1 Study Deliverables
-
1.2 Study Assumptions
-
1.3 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Rising Incidence of Chronic Diseases
-
4.2.2 Increasing Technological Advancements
-
-
4.3 Market Restraints
-
4.3.1 Scarcity of Skilled Labor and Healthcare Professionals
-
-
4.4 Porter's Five Force Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Product Type
-
5.1.1 Analyzers
-
5.1.1.1 Automated
-
5.1.1.2 Semi-Automated
-
-
5.1.2 Reagents
-
5.1.2.1 Luminophore Markers
-
5.1.2.2 Enzymatic Markers
-
-
5.1.3 Consumables
-
-
5.2 By Application
-
5.2.1 Oncology
-
5.2.2 Autoimmune Disorder
-
5.2.3 Infectious Disease
-
5.2.4 Cardiovascular Disease
-
5.2.5 Endocrine Disorders
-
5.2.6 Others
-
-
5.3 By End User
-
5.3.1 Pharmaceutical and Biotechnology Companies
-
5.3.2 Hospital and Clinical Laboratories
-
5.3.3 Others
-
-
5.4 Geography
-
5.4.1 North America
-
5.4.1.1 United States
-
5.4.1.2 Canada
-
5.4.1.3 Mexico
-
-
5.4.2 Europe
-
5.4.2.1 Germany
-
5.4.2.2 United Kingdom
-
5.4.2.3 France
-
5.4.2.4 Italy
-
5.4.2.5 Spain
-
5.4.2.6 Rest of Europe
-
-
5.4.3 Asia-Pacific
-
5.4.3.1 China
-
5.4.3.2 Japan
-
5.4.3.3 India
-
5.4.3.4 Australia
-
5.4.3.5 South Korea
-
5.4.3.6 Rest of Asia-Pacific
-
-
5.4.4 Middle-East and Africa
-
5.4.4.1 GCC
-
5.4.4.2 South Africa
-
5.4.4.3 Rest of Middle-East and Africa
-
-
5.4.5 South America
-
5.4.5.1 Brazil
-
5.4.5.2 Argentina
-
5.4.5.3 Rest of South America
-
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 F. Hoffmann-La Roche AG
-
6.1.2 Mindray Medical International Limited
-
6.1.3 Siemens Healthcare GmbH
-
6.1.4 Beckman Coulter Inc. (Danaher Corporation)
-
6.1.5 DiaSorin S.p.A.
-
6.1.6 Sysmex Corporation
-
6.1.7 Randox Laboratories Ltd.
-
6.1.8 Tosoh Corporation
-
6.1.9 Shenzhen New Industries Biomedical Engineering Co., Ltd.
-
6.1.10 BioMerieux
-
*List Not Exhaustive -
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The Chemiluminescence Immunoassay (CLIA) Market market is studied from 2018 - 2026.
What is the growth rate of Chemiluminescence Immunoassay (CLIA) Market?
The Chemiluminescence Immunoassay (CLIA) Market is growing at a CAGR of 6.6% over the next 5 years.
Which region has highest growth rate in Chemiluminescence Immunoassay (CLIA) Market?
Asia Pacific is growing at the highest CAGR over 2021- 2026.
Which region has largest share in Chemiluminescence Immunoassay (CLIA) Market?
North America holds highest share in 2021.
Who are the key players in Chemiluminescence Immunoassay (CLIA) Market?
F. Hoffmann-La Roche AG, Mindray Medical International Limited, Siemens Healthcare GmbH, Beckman Coulter Inc. (Danaher Corporation), DiaSorin S.p.A. are the major companies operating in Chemiluminescence Immunoassay (CLIA) Market.
